CBT
CBT
NYSE · Chemicals

Cabot Corp

$85.68
+4.40 (+5.41%)
As of May 9, 1:21 AM ET ·
Financial Highlights (FY 2026)
Revenue
3.51B
Net Income
313.26M
Gross Margin
25.3%
Profit Margin
8.9%
Rev Growth
-4.9%
D/E Ratio
0.73
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 25.3% 25.3% 49.7% 49.7%
Operating Margin 16.7% 15.1% 9.8% 10.6%
Profit Margin 8.9% 8.5% 7.8% 8.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.51B 3.70B 185.80M 154.67M
Gross Profit 889.75M 935.88M 92.35M 76.88M
Operating Income 587.89M 556.54M 18.27M 16.44M
Net Income 313.26M 296.55M 14.53M 13.23M
Gross Margin 25.3% 25.3% 49.7% 49.7%
Operating Margin 16.7% 15.1% 9.8% 10.6%
Profit Margin 8.9% 8.5% 7.8% 8.6%
Rev Growth -4.9% -4.9% +7.5% +12.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 926.53M 926.53M 777.42M 779.25M
Total Equity 1.27B 1.27B 2.58B 2.20B
D/E Ratio 0.73 0.73 0.30 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 726.84M 726.30M 24.94M 19.49M
Free Cash Flow 7.01M 6.93M